Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?

Maureen A SmytheCarly BurnsQianyue Liu Candice L Garwood

Published in: The Annals of pharmacotherapy (2021)

Concurrent use of dexamethasone and apixaban or rivaroxaban in hospitalized COVID-19 patients with laboratory evidence of COVID coagulopathy should be avoided until higher-quality data are available.

Keyphrases

coronavirus disease
sars cov
venous thromboembolism
atrial fibrillation
low dose
high dose
respiratory syndrome coronavirus
pulmonary embolism
electronic health record
emergency department
machine learning
squamous cell carcinoma
big data
radiation therapy
risk assessment
drug induced
rectal cancer